Literature DB >> 20392187

Severity of patellar luxation and frequency of concomitant cranial cruciate ligament rupture in dogs: 162 cases (2004-2007).

Courtney A Campbell1, Christopher L Horstman, David R Mason, Richard B Evans.   

Abstract

OBJECTIVE: To evaluate severity of medial patellar luxation (MPL) and frequency of concomitant cranial cruciate ligament rupture (CCLR) in dogs.
DESIGN: Retrospective case series. ANIMALS: 162 dogs (266 stifle joints). PROCEDURES: Medical records of 162 small-breed dogs with MPL were reviewed. Signalment, body weight, luxation grade, bilateral or unilateral MPL, CCLR, and difference in luxation grades between stifle joints were evaluated. Association between severity of MPL and CCLR was investigated.
RESULTS: 58 dogs had unilateral MPL, and 104 dogs had bilateral MPL. Dogs ranged from 8.4 months to 16.7 years of age (mean, 5.7 years), and mean body weight was 5.45 kg (12 lb). Forty-one percent of all dogs had concomitant CCLR. Mean age for dogs with MPL alone was 3.0 years, which differed significantly from mean age of dogs with MPL and concomitant CCLR (7.8 years). Dogs with grade IV MPL were significantly more likely to have concomitant CCLR than were dogs with any other grade of MPL. In dogs with bilateral MPL and unilateral CCLR, there was a significantly higher grade of luxation in the stifle joint with CCLR. CONCLUSIONS AND CLINICAL RELEVANCE: Small-breed dogs with MPL and concomitant CCLR were older than were dogs with only MPL. Dogs with grade IV MPL were more likely to have CCLR than were dogs with other grades of MPL. Most dogs with concomitant CCLR had a higher MPL grade in the affected stifle joint than in the intact joint. These findings should be beneficial in client education and clinical diagnosis.

Entities:  

Mesh:

Year:  2010        PMID: 20392187     DOI: 10.2460/javma.236.8.887

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  9 in total

1.  Comparison of complication rates of unilateral, staged bilateral, and single-session bilateral surgery for the treatment of bilateral medial patellar luxation in dogs.

Authors:  Bronwyn A Fullagar; Päivi Rajala-Schultz; Bianca F Hettlich
Journal:  Can Vet J       Date:  2017-01       Impact factor: 1.008

2.  Comparison of tibial plateau angles in small and large breed dogs.

Authors:  Lillian Su; Katy L Townsend; Jennifer Au; Thomas E Wittum
Journal:  Can Vet J       Date:  2015-06       Impact factor: 1.008

3.  The epidemiology of cruciate ligament rupture in an insured Swedish dog population.

Authors:  Karolina Engdahl; Ulf Emanuelson; Odd Höglund; Annika Bergström; Jeanette Hanson
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

Review 4.  Patellar luxation in dogs.

Authors:  Francesco Di Dona; Giovanni Della Valle; Gerardo Fatone
Journal:  Vet Med (Auckl)       Date:  2018-05-31

5.  Tibial tuberosity transposition advancement for treatment of concomitant cranial cruciate ligament rupture and medial patellar luxation in four feline stifles.

Authors:  Edyta Bula; Karen L Perry
Journal:  JFMS Open Rep       Date:  2021-09-18

6.  Inter- and Intra-Observer Variations in Radiographic Evaluation of Pelvic Limbs in Yorkshire Terriers with Cranial Cruciate Ligament Rupture and Patellar Luxation.

Authors:  Karol Ševčík; Marián Hluchý; Marieta Ševčíková; Michal Domaniža; Valent Ledecký
Journal:  Vet Sci       Date:  2022-04-10

7.  Positive outcomes after surgical correction of grade IV medial patellar luxation in small breed dogs.

Authors:  Mitsuhiro Isaka
Journal:  Open Vet J       Date:  2022-05-30

8.  The epidemiology of patellar luxation in dogs attending primary-care veterinary practices in England.

Authors:  Dan G O'Neill; Richard L Meeson; Adam Sheridan; David B Church; Dave C Brodbelt
Journal:  Canine Genet Epidemiol       Date:  2016-06-08

9.  Lesions in canine stifle joints due to trochleoplasties as treatment for medial patellar luxation.

Authors:  Johannes Hans van der Zee
Journal:  J S Afr Vet Assoc       Date:  2015-07-01       Impact factor: 1.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.